Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis.

Shah S, Casas JP, Drenos F, Whittaker J, Deanfield J, Swerdlow DI, Holmes MV, Kivimaki M, Langenberg C, Wareham N, Gertow K, Sennblad B, Strawbridge RJ, Baldassarre D, Veglia F, Tremoli E, Gigante B, de Faire U, Kumari M, Talmud PJ, Hamsten A, Humphries SE, Hingorani AD.

Circ Cardiovasc Genet. 2013 Feb;6(1):63-72. doi: 10.1161/CIRCGENETICS.112.963140. Epub 2012 Dec 28.

2.

Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.

Isaacs A, Willems SM, Bos D, Dehghan A, Hofman A, Ikram MA, Uitterlinden AG, Oostra BA, Franco OH, Witteman JC, van Duijn CM.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2233-9. doi: 10.1161/ATVBAHA.113.301236. Epub 2013 Jun 13.

3.

Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).

Paramsothy P, Knopp RH, Bertoni AG, Blumenthal RS, Wasserman BA, Tsai MY, Rue T, Wong ND, Heckbert SR.

J Am Coll Cardiol. 2010 Sep 21;56(13):1034-41. doi: 10.1016/j.jacc.2010.01.073.

4.

Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women.

Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR.

Vasc Health Risk Manag. 2012;8:31-8. doi: 10.2147/VHRM.S27963. Epub 2012 Jan 16.

5.

High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men.

Zaid M, Fujiyoshi A, Miura K, Abbott RD, Okamura T, Takashima N, Torii S, Saito Y, Hisamatsu T, Miyagawa N, Ohkubo T, Kadota A, Sekikawa A, Maegawa H, Nakamura Y, Mitsunami K, Ueshima H; SESSA Research group.

Atherosclerosis. 2015 Apr;239(2):444-50. doi: 10.1016/j.atherosclerosis.2015.01.031. Epub 2015 Jan 31.

6.

High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Mackey RH, Greenland P, Goff DC Jr, Lloyd-Jones D, Sibley CT, Mora S.

J Am Coll Cardiol. 2012 Aug 7;60(6):508-16. doi: 10.1016/j.jacc.2012.03.060. Epub 2012 Jul 11.

8.

Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).

Ikeda K, Takahashi T, Yamada H, Matsui K, Sawada T, Nakamura T, Matsubara H; (for the PEACE Investigators).

Eur J Prev Cardiol. 2013 Dec;20(6):1069-79. doi: 10.1177/2047487312451539. Epub 2012 Jun 11.

PMID:
22689416
9.

Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration.

Burgess S, Davey Smith G.

Ophthalmology. 2017 Aug;124(8):1165-1174. doi: 10.1016/j.ophtha.2017.03.042. Epub 2017 Apr 26.

10.

The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.

Akbas HS, Basyigit S, Suleymanlar I, Kemaloglu D, Koc S, Davran F, Demir I, Suleymanlar G.

Lipids Health Dis. 2010 Aug 30;9:92. doi: 10.1186/1476-511X-9-92.

11.

Mendelian randomization of blood lipids for coronary heart disease.

Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, Tragante V, van Iperen EP, Sivapalaratnam S, Shah S, Elbers CC, Shah T, Engmann J, Giambartolomei C, White J, Zabaneh D, Sofat R, McLachlan S; UCLEB consortium, Doevendans PA, Balmforth AJ, Hall AS, North KE, Almoguera B, Hoogeveen RC, Cushman M, Fornage M, Patel SR, Redline S, Siscovick DS, Tsai MY, Karczewski KJ, Hofker MH, Verschuren WM, Bots ML, van der Schouw YT, Melander O, Dominiczak AF, Morris R, Ben-Shlomo Y, Price J, Kumari M, Baumert J, Peters A, Thorand B, Koenig W, Gaunt TR, Humphries SE, Clarke R, Watkins H, Farrall M, Wilson JG, Rich SS, de Bakker PI, Lange LA, Davey Smith G, Reiner AP, Talmud PJ, Kivimäki M, Lawlor DA, Dudbridge F, Samani NJ, Keating BJ, Hingorani AD, Casas JP.

Eur Heart J. 2015 Mar 1;36(9):539-50. doi: 10.1093/eurheartj/eht571. Epub 2014 Jan 27.

12.

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease.

Maki KC, Davidson MH, Dicklin MR, Bell M, Witchger M, Feinstein SB.

J Clin Lipidol. 2011 May-Jun;5(3):141-51. doi: 10.1016/j.jacl.2011.02.003. Epub 2011 Feb 12.

PMID:
21600518
13.

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.

Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R Sr, Kondos GT, Perez A, Chen Z, Mazzone T.

Circulation. 2008 Apr 22;117(16):2123-30. doi: 10.1161/CIRCULATIONAHA.107.746610. Epub 2008 Apr 14.

14.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
15.

Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe.

Taylor AJ, Villines TC, Stanek EJ.

Eur Heart J. 2012 Dec;33(23):2939-45. doi: 10.1093/eurheartj/ehs105. Epub 2012 May 7.

PMID:
22564353
16.

Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.

Smith JG, Luk K, Schulz CA, Engert JC, Do R, Hindy G, Rukh G, Dufresne L, Almgren P, Owens DS, Harris TB, Peloso GM, Kerr KF, Wong Q, Smith AV, Budoff MJ, Rotter JI, Cupples LA, Rich S, Kathiresan S, Orho-Melander M, Gudnason V, O'Donnell CJ, Post WS, Thanassoulis G; Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Extracoronary Calcium Working Group.

JAMA. 2014 Nov 5;312(17):1764-71. doi: 10.1001/jama.2014.13959.

17.

Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.

Burgess S, Freitag DF, Khan H, Gorman DN, Thompson SG.

PLoS One. 2014 Oct 10;9(10):e108891. doi: 10.1371/journal.pone.0108891. eCollection 2014.

18.

Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.

Carey VJ, Bishop L, Laranjo N, Harshfield BJ, Kwiat C, Sacks FM.

Am J Cardiol. 2010 Sep 15;106(6):757-63. doi: 10.1016/j.amjcard.2010.05.002. Epub 2010 Aug 1.

19.

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.

Burgess S, Harshfield E.

Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):124-30. doi: 10.1097/MED.0000000000000230. Review.

20.

Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.

Riccioni G, Bazzano LA, Bucciarelli T, Mancini B, di Ilio E, D'Orazio N.

Expert Opin Pharmacother. 2008 Oct;9(14):2403-8. doi: 10.1517/14656566.9.14.2403 .

PMID:
18778179

Supplemental Content

Support Center